{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T15:37:05Z","timestamp":1790869025780,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","trasci.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1016\/j.transci.2010.09.003","type":"journal-article","created":{"date-parts":[[2010,11,12]],"date-time":"2010-11-12T06:27:03Z","timestamp":1289543223000},"page":"387-391","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["The risk of transmitting prion disease by blood or plasma products"],"prefix":"10.1016","volume":"43","author":[{"given":"Richard","family":"Knight","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.transci.2010.09.003_b0005","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/39057","article-title":"Transmission to mice indicates that new variant CJD is caused by the BSE agent","volume":"389","author":"Bruce","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.transci.2010.09.003_b0010","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/383685a0","article-title":"Molecular analysis of prion strain variation and the aetiology of \u201cnew variant\u201d CJD","volume":"383","author":"Collinge","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.transci.2010.09.003_b0015","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1046\/j.1423-0410.1999.7640203.x","article-title":"The relationship between new variant Creutzfeldt\u2013Jakob disease and bovine spongiform encephalopathy","volume":"76","author":"Knight","year":"1999","journal-title":"Vox Sang"},{"key":"10.1016\/j.transci.2010.09.003_b0020","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0140-6736(04)15486-X","article-title":"Possible transmission of variant Creutzfeldt\u2013Jakob disease by blood transfusion","volume":"363","author":"Llewelyn","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.transci.2010.09.003_b0025","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1016\/S0140-6736(06)69835-8","article-title":"Clinical presentation and pre-mortem diagnosis of variant Creutzfeldt\u2013Jakob disease associated with blood transfusion: a case report","volume":"368","author":"Wroe","year":"2006","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.transci.2010.09.003_b0170","article-title":"Fourth case of transfusion-associated variant-CJD","volume":"1","author":"Health Protection Agency","year":"2007","journal-title":"Health Protect Report"},{"key":"10.1016\/j.transci.2010.09.003_b0035","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0140-6736(04)16811-6","article-title":"Preclinical vCJD after blood transfusion in a PRNP 129 heterozygous patient","volume":"364","author":"Peden","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.transci.2010.09.003_b0040","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1423-0410.2006.00833.x","article-title":"Creutzfeldt\u2013Jakob disease and blood transfusion: results of the UK transfusion. Medicine epidemiological review study","volume":"91","author":"Hewitt","year":"2006","journal-title":"Vox Sang"},{"key":"10.1016\/j.transci.2010.09.003_b0045","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1365-2516.2009.02181.x","article-title":"Variant CJD infection in the spleen of a neurologically asymptomatic UK adult patient with haemophilia","volume":"16","author":"Peden","year":"2010","journal-title":"Haemophilia"},{"issue":"Suppl. 5","key":"10.1016\/j.transci.2010.09.003_b0050","first-page":"32","article-title":"Creutzfeldt\u2013Jakob disease: reflections on the risk from blood product therapy","volume":"13","author":"Brown","year":"2007","journal-title":"Haemophilia"},{"key":"10.1016\/j.transci.2010.09.003_b0055","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1365-2141.2005.05796.x","article-title":"Managing the risk of transmission of variant CJD by blood products","volume":"132","author":"Ludlam","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1016\/j.transci.2010.09.003_b0060","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1423-0410.2009.01205.x","article-title":"Variant Creutzfeldt\u2013Jakob disease and exposure to fractionated plasma products","volume":"97","author":"Ward","year":"2009","journal-title":"Vox Sang"},{"key":"10.1016\/j.transci.2010.09.003_b0175","series-title":"Prion biology and diseases","first-page":"1","author":"Prusiner","year":"2004"},{"key":"10.1016\/j.transci.2010.09.003_b0070","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1212\/01.wnl.0000302186.10596.f6","article-title":"Transmissible spongiform encephalopathy in the 21st century. Neuroscience for the clinical neurologist","volume":"70","author":"Brown","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.transci.2010.09.003_b0075","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/path.1580","article-title":"Prevalence of lymphoreticular prion protein accumulation in UK tissue samples","volume":"203","author":"Hilton","year":"2004","journal-title":"J Pathol"},{"key":"10.1016\/j.transci.2010.09.003_b0080","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S1474-4422(06)70413-6","article-title":"Predicting susceptibility and incubation time of human-to-human transmission of vCJD","volume":"5","author":"Bishop","year":"2006","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.transci.2010.09.003_b0085","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1098\/rsif.2004.0017","article-title":"Projections of the future course of the primary vCJD epidemic in the UK: inclusion of subclinical infection and the possibility of wider genetic susceptibility","volume":"2","author":"Clarke","year":"2005","journal-title":"J Royal Soc Interf"},{"key":"10.1016\/j.transci.2010.09.003_b0090","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1046\/j.1537-2995.1998.38998408999.x","article-title":"The distribution of infectivity in blood components and plasma derivatives in experimental models of transmissible spongiform encephalopathy","volume":"38","author":"Brown","year":"1998","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2010.09.003_b0095","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1046\/j.1537-2995.1999.39111169.x","article-title":"Further studies of blood infectivity in an experimental model of transmissible spongiform encephalopathy, with an explanation of why blood components do not transmit Creutzfeldt\u2013Jakob disease in humans","volume":"39","author":"Brown","year":"1999","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2010.09.003_b0100","unstructured":"Cerven\u00e1kov\u00e1 L. Infectivity in blood of experimental mice: vCJD update. Cambridge Healthtech Institute 8th Annual Meeting 2002 \u201cTransmissible Spongiform Encephalopathy\u2019s\u201d, Washington, DC."},{"key":"10.1016\/j.transci.2010.09.003_b0110","unstructured":"Det Norske Veritas. Risk of infection from variant CJD in blood; 2004. http:\/\/www.dnv.com\/news_events\/news\/2004\/riskofinfectionfromvariantcjdinblood.asp [accessed 16.10.09]."},{"key":"10.1016\/j.transci.2010.09.003_b0120","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/S0140-6736(00)02719-7","article-title":"Transmission of BSE by blood transfusion in sheep","volume":"356","author":"Houston","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.transci.2010.09.003_b0125","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1099\/0022-1317-83-11-2897","article-title":"Transmission of prion diseases by blood transfusion","volume":"83","author":"Hunter","year":"2002","journal-title":"J Gen Virol"},{"key":"10.1016\/j.transci.2010.09.003_b0130","doi-asserted-by":"crossref","first-page":"4739","DOI":"10.1182\/blood-2008-04-152520","article-title":"Prion diseases are efficiently transmitted by blood transfusion in sheep","volume":"112","author":"Houston","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.transci.2010.09.003_b0135","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0140-6736(04)16812-8","article-title":"Effectiveness of leucoreduction for removal of infectivity of transmissible spongiform encephalopathies from blood","volume":"364","author":"Gregori","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.transci.2010.09.003_b0180","doi-asserted-by":"crossref","first-page":"b1442","DOI":"10.1136\/bmj.b1442","article-title":"Prevalence of disease related prion protein in anonymous tonsil specimens in Britain: a cross sectional opportunistic survey","volume":"338","author":"Clewley","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.transci.2010.09.003_b0145","unstructured":"Spongiform Encephalopathy Advisory Committee. Position statement: prevalence of subclinical variant Creutzfeldt\u2013Jakob disease infections; 2008. http:\/\/www.seac.gov.uk\/statements\/state-cjd-infections.pdf [accessed 16.10.09]."},{"key":"10.1016\/j.transci.2010.09.003_b0150","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1034\/j.1600-0404.2003.00199.x","article-title":"The normal population distribution of PRPN codon 129 polymorphism","volume":"108","author":"Nurmi","year":"2003","journal-title":"Acta Scand Neurol"},{"key":"10.1016\/j.transci.2010.09.003_b0155","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1016\/S0140-6736(09)61568-3","volume":"374","author":"Kaski","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.transci.2010.09.003_b0160","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1016\/S0140-6736(06)69897-8","article-title":"Reduction in infectivity of endogenous transmissible spongiform encephalopathies present in blood by adsorption to selective affinity resins","volume":"368","author":"Gregori","year":"2006","journal-title":"Lancet"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050210001473?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050210001473?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T08:47:53Z","timestamp":1761468473000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473050210001473"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["S1473050210001473"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2010.09.003","relation":{},"ISSN":["1473-0502"],"issn-type":[{"value":"1473-0502","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The risk of transmitting prion disease by blood or plasma products","name":"articletitle","label":"Article Title"},{"value":"Transfusion and Apheresis Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transci.2010.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Ltd. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}